Laboratory of Genetics, Immunology and Human Pathologies, Tunis, Tunisia.
Diagn Pathol. 2012 Aug 10;7:93. doi: 10.1186/1746-1596-7-93.
Hemophilia A is an X linked recessive hemorrhagic disorder caused by mutations in the F8 gene that lead to qualitative and/or quantitative deficiencies of coagulation factor VIII (FVIII). Molecular diagnosis of hemophilia A is challenging because of the high number of different causative mutations that are distributed throughout the large F8 gene. Molecular studies of these mutations are essential in order to reinforce our understanding of their pathogenic effect responsible for the disorder.
In this study we have performed molecular analysis of 28 Tunisian hemophilia A patients and analyzed the F8 mutation spectrum.
We screened the presence of intron 22 and intron 1 inversion in severe hemophilia A patients by southern blotting and polymerase chain reaction (PCR). Detection of point mutations was performed by dHPLC/sequencing of the coding F8 gene region. We predict the potential functional consequences of novel missense mutations with bioinformatics approaches and mapping of their spatial positions on the available FVIII 3D structure.
We identified 23 different mutations in 28 Tunisian hemophilia A patients belonging to 22 unrelated families. The identified mutations included 5 intron 22 inversions, 7 insertions, 4 deletions and 7 substitutions. In total 18 point mutations were identified, of which 9 are located in exon 14, the most mutated exonic sequence in the F8 gene. Among the 23 mutations, 8 are novel and not deposited in the HAMSTeRS database nor described in recently published articles.
The mutation spectrum of Tunisian hemophilia A patients is heterogeneous with the presence of some characteristic features.
The virtual slide(s) for this article can be found here:http://www.diagnosticpathology.diagnomx.eu/vs/1693269827490715.
血友病 A 是一种 X 连锁隐性遗传性出血性疾病,由 F8 基因的突变引起,导致凝血因子 VIII(FVIII)的质量和/或数量不足。由于引起疾病的突变数量众多,分布在 F8 基因的大片段中,因此血友病 A 的分子诊断具有挑战性。对这些突变进行分子研究对于加深我们对导致疾病的致病效应的理解至关重要。
在这项研究中,我们对 28 名突尼斯血友病 A 患者进行了分子分析,并分析了 F8 基因突变谱。
我们通过 Southern 印迹和聚合酶链反应(PCR)筛查严重血友病 A 患者的内含子 22 和内含子 1 倒位。通过 dHPLC/测序对编码 F8 基因区域的点突变进行检测。我们通过生物信息学方法预测新错义突变的潜在功能后果,并在可用的 FVIII 3D 结构上对其空间位置进行映射。
我们在 28 名突尼斯血友病 A 患者中发现了 23 种不同的突变,这些突变属于 22 个无关家族。鉴定的突变包括 5 种内含子 22 倒位、7 种插入、4 种缺失和 7 种取代。总共鉴定出 18 种点突变,其中 9 种位于外显子 14,这是 F8 基因中突变最多的外显子序列。在 23 种突变中,有 8 种是新的,未在 HAMSTeRS 数据库中登记,也未在最近发表的文章中描述。
突尼斯血友病 A 患者的突变谱具有异质性,存在一些特征性特征。